Defiance US 100 Tech AI Moat ETF (AIX)
Live price chart, market sentiment, and community perspectives for Defiance US 100 Tech AI Moat ETF (NASDAQ: AIX).
Live price chart, market sentiment, and community perspectives for Defiance US 100 Tech AI Moat ETF (NASDAQ: AIX).
On our desk, we are monitoring the structural shift away from traditional software toward hardware-heavy AI beneficiaries. AIX's methodology specifically targets this by isolating firms with hard technological moats—like Nvidia, Broadcom, and Palantir—while trimming vulnerable application platforms. However, with AUM sitting under $1 million and a P/E multiple around 41.74, liquidity requires careful monitoring before scaling into positions.
Reviewing the June 2026 prospectus and recent price action around $23.23, the fund has a 0.65% expense ratio and tracks the Indxx US 100 Tech AI Moat Index. While retail investors remain active in the AI theme, there is an observable uptick in caution, leading participants to weigh the fund's heavy allocation to mega-cap innovators against liquidity constraints in its early trading phase.
When evaluating AI thematic ETFs for institutional rotation, our quant framework focuses on screening out enterprise software prone to generative AI displacement. AIX explicitly builds its index around this thesis, overweighting hardware leaders like AMD, Micron, and Microsoft. Analysts should verify component rebalancing rules to ensure the moat definition adapts as foundational models evolve.
From a portfolio construction standpoint, the exclusion of vulnerable digital services and application software providers is the primary differentiator for AIX compared to broad tech ETFs. As we advise clients balancing risk into the fall, understanding how the underlying index defines an 'AI moat' is critical for avoiding false security in high-multiple growth equities.
Looking at the full holdings data, top allocations are heavily anchored by foundational tech and AI infrastructure names including PLTR at 6.27%, MSFT at 5.93%, and NVDA at 5.05%. Risk managers must assess whether this concentration risk mirrors standard mega-cap tech indexes or if the sector filtering provides genuine downside insulation during market pullbacks.
Explore plasma cleansing, somatic organ swaps, and BCI.